BioAlta has named Yong Ben its chief medical officer. Ben comes to San Diego-based BioAlta from AstraZeneca (NYSE: [[ticker:AZN]]), where he most recently served as global clinical lead in immune-oncology. BioAlta is developing conditionally active biologic proteins (CABs), which deliver a therapeutic payload or spark an immune response in specific areas of the body.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
